Transitioning to composite bacterial mutagenicity models in ICH M7 (Q)SAR analyses.
暂无分享,去创建一个
Naomi L Kruhlak | Lidiya Stavitskaya | Curran Landry | Marlene T Kim | Kevin P Cross | Roustem Saiakhov | Suman Chakravarti | Marlene T. Kim | K. Cross | N. Kruhlak | S. Chakravarti | R. Saiakhov | L. Stavitskaya | Curran Landry
[1] Nigel Greene,et al. It's difficult, but important, to make negative predictions. , 2016, Regulatory toxicology and pharmacology : RTP.
[2] Heather Scott,et al. Ames positive boronic acids are not all eukaryotic genotoxins. , 2015, Mutation research. Genetic toxicology and environmental mutagenesis.
[3] Roustem D Saiakhov,et al. Computing similarity between structural environments of mutagenicity alerts , 2019, Mutagenesis.
[4] D. Strauss,et al. Translating New Science Into the Drug Review Process: The US FDA's Division of Applied Regulatory Science. , 2018 .
[5] E. Zeiger,et al. Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals. , 1987, Environmental mutagenesis.
[6] Glenn J. Myatt,et al. LeadScope: Software for Exploring Large Sets of Screening Data , 2000, J. Chem. Inf. Comput. Sci..
[7] Scott Boyer,et al. Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities. , 2013, Regulatory toxicology and pharmacology : RTP.
[8] M T D Cronin,et al. A review of the electrophilic reaction chemistry involved in covalent DNA binding , 2010, Critical reviews in toxicology.
[9] Neal F. Cariello,et al. Comparison of the computer programs DEREK and TOPKAT to predict bacterial mutagenicity. Deductive Estimate of Risk from Existing Knowledge. Toxicity Prediction by Komputer Assisted Technology. , 2002, Mutagenesis.
[10] Gilles Klopman,et al. Optimizing Predictive Performance of CASE Ultra Expert System Models Using the Applicability Domains of Individual Toxicity Alerts , 2012, J. Chem. Inf. Model..
[11] Luis G Valerio,et al. Characterization and validation of an in silico toxicology model to predict the mutagenic potential of drug impurities. , 2012, Toxicology and applied pharmacology.
[12] N. Kruhlak,et al. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods. , 2006, Regulatory toxicology and pharmacology : RTP.
[13] Craig Zwickl,et al. An evaluation of in-house and off-the-shelf in silico models: implications on guidance for mutagenicity assessment. , 2015, Regulatory toxicology and pharmacology : RTP.
[14] Lemont B. Kier,et al. New predictors for several ADME/Tox properties: Aqueous solubility, human oral absorption, and Ames genotoxicity using topological descriptors , 2004, Molecular Diversity.
[15] E. Zeiger,et al. The Ames Salmonella/microsome mutagenicity assay. , 2000, Mutation research.
[16] J. Kazius,et al. Derivation and validation of toxicophores for mutagenicity prediction. , 2005, Journal of medicinal chemistry.
[17] Gilles Klopman,et al. Effectiveness of CASE Ultra Expert System in Evaluating Adverse Effects of Drugs , 2013, Molecular informatics.
[18] Samuel J. Webb,et al. Self organising hypothesis networks: a new approach for representing and structuring SAR knowledge , 2014, Journal of Cheminformatics.
[19] Romualdo Benigni,et al. Mechanisms of chemical carcinogenicity and mutagenicity: a review with implications for predictive toxicology. , 2011, Chemical reviews.
[20] Tudor I. Oprea,et al. In silico toxicology protocols. , 2018, Regulatory toxicology and pharmacology : RTP.
[21] R. Saracci,et al. Describing the validity of carcinogen screening tests. , 1979, British Journal of Cancer.
[22] Errol Zeiger,et al. Measuring Intra-Assay Agreement for the Ames Salmonella Assay , 1991 .
[23] Matthew D Segall,et al. Addressing toxicity risk when designing and selecting compounds in early drug discovery. , 2014, Drug discovery today.
[24] Nigel Greene,et al. Evaluation of a statistics-based Ames mutagenicity QSAR model and interpretation of the results obtained. , 2016, Regulatory toxicology and pharmacology : RTP.
[25] GUIDANCE DOCUMENT,et al. Guidance on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use , 2008 .
[26] E. Zeiger,et al. Salmonella mutagenicity test results for 250 chemicals. , 1983, Environmental mutagenesis.
[27] F. Guengerich,et al. Mechanisms of formation of DNA adducts from ethylene dihalides, vinyl halides, and arylamines. , 1994, Drug metabolism reviews.
[28] Lidiya Stavitskaya,et al. Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity. , 2016, Regulatory toxicology and pharmacology : RTP.
[29] Krista Dobo,et al. Determination of compound-specific acceptable daily intakes for 11 mutagenic carcinogens used in pharmaceutical synthesis. , 2013, Regulatory toxicology and pharmacology : RTP.
[30] E. Zeiger,et al. Salmonella mutagenicity tests: IV. Results from the testing of 300 chemicals , 1988, Environmental and molecular mutagenesis.
[31] Lidiya Stavitskaya,et al. Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses. , 2016, Regulatory toxicology and pharmacology : RTP.
[32] Lidiya Stavitskaya,et al. Principles and procedures for handling out-of-domain and indeterminate results as part of ICH M7 recommended (Q)SAR analyses , 2018, Regulatory toxicology and pharmacology : RTP.
[33] Lutz Müller,et al. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. , 2005, Mutation research.
[34] Lutz Müller,et al. A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity. , 2006, Regulatory toxicology and pharmacology : RTP.
[35] Andrew Teasdale,et al. ICH M7: Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk , 2017 .
[36] A. Giuliani,et al. Computer-assisted analysis of interlaboratory Ames test variability. , 1988, Journal of toxicology and environmental health.
[37] Alessandro Giuliani,et al. Improvement of quantitative structure–activity relationship (QSAR) tools for predicting Ames mutagenicity: outcomes of the Ames/QSAR International Challenge Project , 2018, Mutagenesis.
[38] D. Gatehouse,et al. Bacterial mutagenicity assays: test methods. , 2012, Methods in molecular biology.
[39] Mark W Powley,et al. (Q)SAR assessments of potentially mutagenic impurities: a regulatory perspective on the utility of expert knowledge and data submission. , 2015, Regulatory toxicology and pharmacology : RTP.
[40] Nigel Greene,et al. A practical application of two in silico systems for identification of potentially mutagenic impurities. , 2015, Regulatory toxicology and pharmacology : RTP.
[41] Lidiya Stavitskaya,et al. Establishing best practise in the application of expert review of mutagenicity under ICH M7. , 2015, Regulatory toxicology and pharmacology : RTP.
[42] E. Zeiger,et al. Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals. , 1986, Environmental mutagenesis.
[43] J. Ashby,et al. Prediction of Salmonella mutagenicity. , 1996, Mutagenesis.
[44] Jun Li,et al. In silico and in vitro genotoxicity evaluation of descarboxyl levofloxacin, an impurity in levofloxacin , 2014, Drug and chemical toxicology.
[45] H. Seifried,et al. A compilation of two decades of mutagenicity test results with the Ames Salmonella typhimurium and L5178Y mouse lymphoma cell mutation assays. , 2006, Chemical research in toxicology.
[46] B A Bridges,et al. Use of a simplified fluctuation test to detect low levels of mutagens. , 1976, Mutation research.
[47] B. Ames,et al. Revised methods for the Salmonella mutagenicity test. , 1983, Mutation research.
[48] R. Tennant,et al. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. , 1991, Mutation research.
[49] Klaus-Robert Müller,et al. Benchmark Data Set for in Silico Prediction of Ames Mutagenicity , 2009, J. Chem. Inf. Model..
[50] B. Ames,et al. An improved bacterial test system for the detection and classification of mutagens and carcinogens. , 1973, Proceedings of the National Academy of Sciences of the United States of America.
[51] Lidiya Stavitskaya,et al. Construction and application of (Q)SAR models to predict chemical‐induced in vitro chromosome aberrations , 2018, Regulatory toxicology and pharmacology : RTP.
[52] Lidiya Stavitskaya,et al. Chemical Structure-Based and Toxicogenomic Models , 2015 .
[53] Carol A Marchant,et al. In Silico Tools for Sharing Data and Knowledge on Toxicity and Metabolism: Derek for Windows, Meteor, and Vitic , 2008, Toxicology mechanisms and methods.
[54] R D Benz,et al. (Q)SAR Modeling and Safety Assessment in Regulatory Review , 2012, Clinical pharmacology and therapeutics.
[55] J. Ashby. Fundamental structural alerts to potential carcinogenicity or noncarcinogenicity. , 1985, Environmental mutagenesis.
[56] Glenn J. Myatt,et al. CHAPTER 9:In silico Toxicology: An Overview of Toxicity Databases, Prediction Methodologies, and Expert Review , 2017 .
[57] Lidiya Stavitskaya,et al. Ensuring Regulatory Acceptable (Q)SAR Models and Expert Alerts for ICH M7 Reflect Proprietary Chemical Space , 2014 .
[58] N. Kruhlak,et al. In silico screening of chemicals for bacterial mutagenicity using electrotopological E-state indices and MDL QSAR software. , 2005, Regulatory toxicology and pharmacology : RTP.
[59] N. Kruhlak,et al. An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints. , 2006, Regulatory toxicology and pharmacology : RTP.
[60] R. Tennant,et al. Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested in rodents by the U.S. NCI/NTP. , 1988, Mutation research.
[61] Susanne Glowienke,et al. Mutagenicity assessment strategy for pharmaceutical intermediates to aid limit setting for occupational exposure. , 2015, Regulatory toxicology and pharmacology : RTP.
[62] Alexander Amberg,et al. Do Carboxylic/Sulfonic Acid Halides Really Present a Mutagenic and Carcinogenic Risk as Impurities in Final Drug Products? , 2015 .